However, other studies believe that ALK-positive IMT carries a higher risk of local recurrence, while ALK-negative IMT tends to be more aggressive and prone to distant metastasis (Hou et al., 2020; Siemion et al., 2022; Domínguez-Massa et al., 2023). Here, ALK is linked to inflammatory myofibroblastic tumor.